Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

March 13, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions
Mitral RegurgitationAtrial FibrillationAnticoagulation
Interventions
OTHER

early anticoagulation

Anticoagulation prior to transseptal puncture

OTHER

late anticoagulation

Anticoagulation after transseptal puncture

Trial Locations (5)

80-952

Uniwersyteckie Centrum Kliniczne Gdański Uniwersytet Medyczny, Gdansk

Unknown

Górnośląskie Centrum Medyczne im. Leszka Gieca Śląskiego Uniwersytetu Medycznego, Katowice

Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie, Lublin

Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego, Warsaw

60-355

Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan

Sponsors
All Listed Sponsors
collaborator

Medical Research Agency, Poland

OTHER_GOV

collaborator

Soft Communication, Poland

UNKNOWN

lead

National Institute of Cardiology, Warsaw, Poland

OTHER

NCT05305612 - Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions | Biotech Hunter | Biotech Hunter